Showing results for "#USFDA"

Existing USFDA-approved drug shows promise for 2 rare genetic...

Sandhoff and Tay-Sachs diseases cause progressive damage to nerve cells in the brain and spinal cord.

The US Department of Health and Human Services (HHS) in a statement on Sunday said that chloroquine and hydroxychloroquine could be prescribed to...

Drug firm Zydus Cadila on Thursday said it has received final approval from the US health regulator to market generic Lamotrigine extended-release...

Granules India Ltd on Thursday said its foreign subsidiary has received approval from the US health regulator for Butalbital, Acetaminophen and...

Drug maker Lupin on Tuesday said it has received approval from the US health regulator to market Meloxicam capsules, used to treat osteoarthritis...

Drug firm Granules India Friday said its subsidiary has received marketing approval from the US health regulator for Dexmethylphenidate HCl...

Drug firm Granules India on Friday said it has received the US health regulator's approval for Naproxen Sodium and Diphenhydramine Hydrochloride...

Drug firm Zydus Cadila on Friday said it has received final approval from the US health regulator to market Dimethyl Fumarate delayed release...